PLA2G6 and Parkinsonism: This suggests that phospholipase activity is not the only important aspect in iPLA2-VIA mediated cytoprotection, possibly explaining the observation that mutations associated with PLA2G6-associated dystonia-parkinsonism do not disrupt catalytic activity [47].